Allergic Rhinitis Due to Weed Pollen

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Allergic Rhinitis Due to Weed Pollen trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (3 shown)

CompletedPhase 1

NCT06038279

Trial of INI-2004 in Healthy Volunteers and Participants With Allergic Rhinitis.

This is a Phase I/Ib, randomised, double-blind, placebo-controlled study of INI-2004, administered as single or multiple doses. This study will be conducted in…

Australia68 participantsStarted 2023-07-04

Treatment: INI-2004, Placebo

CompletedPhase 4

NCT05040828

Early Intervention in Allergic Patients

As many as 250 million people suffer from allergic rhinitis in China, which has a large population, early use of drugs may help better control the symptoms.This…

China59 participantsStarted 2020-07-01

Treatment: Start taking Montelukast Sodium Tablets 10mg quaque die orally two weeks before peak pollen count., Montelukast Sodium Tablets 10mg quaque die orally was administered after peak pollen count.

CompletedNot Applicable

NCT01686022

Grass Sensitisation and Allergic Rhinitis in Thai Patients

Allergic rhinitis patients are the patients who have nasal symptoms when triggered by indoor or outdoor allergens. Outdoor allergen can be divided into grass, t…

Thailand40 participantsStarted 2012-10

Treatment: Immunoblot